Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease.
Saved in:
| Title: | Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease. |
|---|---|
| Authors: | Rustgi VK; Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.; Center for Liver Diseases and Masses, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Duff SB; Veritas Health Economics Consulting, Inc, Carlsbad, CA, USA., Elsaid MI; Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.; Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA. |
| Source: | Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 347-355. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1941-837X |
|---|---|
| DOI: | 10.1080/13696998.2022.2026702 |
